> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 17 New Inspection Reports, Including Novartis, Genzyme and Baxter
- URL: https://www.fdaweb.com/17-new-inspection-reports-including-novartis-genzyme-and-baxter/
- Published: 2026-11-17T15:38:10.000Z
- Updated: 2026-11-17T15:38:10.000Z
- Author: David McFarland
- Tags: enforcement

FDA added 17 Form 483 inspection reports to its public reading room on 11/16-17, including records involving major pharmaceutical and biologics manufacturers in the U.S. and overseas.

The newly disclosed reports include inspections of Novartis Pharma Stein AG in Switzerland, Glenmark Pharmaceuticals in India, Samchundang Pharma in South Korea, Genzyme in Massachusetts and Baxter Healthcare in Illinois.

The newly posted documents also include older inspection reports involving Antaria Pty Ltd. in Australia and Nortec Quimica in Brazil, both dating to 2023.

The following Form 483s were added:

**Reports Published November 17, 2026**

| **Establishment**                                 | **Inspection Date** | **FDA Report**                                                       |
| ------------------------------------------------- | ------------------- | -------------------------------------------------------------------- |
| Novartis Pharma Stein AG — Switzerland            | 5/19/2026           | [Form 483](https://www.fda.gov/media/196458/download?ref=fdaweb.com) |
| MassBiologics South Coast — Massachusetts         | 8/12/2024           | [Form 483](https://www.fda.gov/media/196457/download?ref=fdaweb.com) |
| Clement J. Zablocki VA Medical Center — Wisconsin | 5/1/2026            | [Form 483](https://www.fda.gov/media/196460/download?ref=fdaweb.com) |

**Reports Published November 16, 2026**

| **Establishment**                              | **Inspection Date** | **FDA Report**                                                       |
| ---------------------------------------------- | ------------------- | -------------------------------------------------------------------- |
| Glenmark Pharmaceuticals Limited — India       | 6/30/2026           | [Form 483](https://www.fda.gov/media/196312/download?ref=fdaweb.com) |
| Samchundang Pharma Co., Ltd. — South Korea     | 5/19/2026           | [Form 483](https://www.fda.gov/media/196313/download?ref=fdaweb.com) |
| Genzyme Corporation — Massachusetts            | 4/9/2026            | [Form 483](https://www.fda.gov/media/196305/download?ref=fdaweb.com) |
| Baxter Healthcare Corporation — Illinois       | 4/2/2026            | [Form 483](https://www.fda.gov/media/196306/download?ref=fdaweb.com) |
| Benjamin D. Elder, MD, PhD — Minnesota         | 3/27/2026           | [Form 483](https://www.fda.gov/media/196314/download?ref=fdaweb.com) |
| Spectrum Laboratory Products Inc. — California | 3/20/2026           | [Form 483](https://www.fda.gov/media/196307/download?ref=fdaweb.com) |
| PETNET Solutions Inc. — Georgia                | 3/2/2026            | PDF link not yet verified                                            |
| Biomat USA Inc. — Ohio                         | 1/28/2026           | [Form 483](https://www.fda.gov/media/196882/download?ref=fdaweb.com) |
| The Hay Exchange Inc. — Florida                | 12/5/2025           | [Form 483](https://www.fda.gov/media/196310/download?ref=fdaweb.com) |
| Baxalta US Inc. — California                   | 9/18/2025           | [Form 483](https://www.fda.gov/media/196880/download?ref=fdaweb.com) |